inositol has been researched along with vasoactive intestinal peptide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakagawa-Yagi, Y; Nakamura, H; Saito, Y; Takada, Y | 1 |
Ecay, TW; Valentich, JD | 1 |
Behar, J; Biancani, P; Billett, G; Hillemeier, C; Rhim, BY; Szewczak, SM | 1 |
McArdle, CA | 1 |
4 other study(ies) available for inositol and vasoactive intestinal peptide
Article | Year |
---|---|
Suppressive effect of carbachol on forskolin-stimulated neurite outgrowth in human neuroblastoma NB-OK1 cells.
Topics: Atropine; Calcium; Calcium Channel Blockers; Carbachol; Cell Line; Colforsin; Cyclic AMP; Drug Interactions; Egtazic Acid; Gallic Acid; Humans; Inositol; Inositol Phosphates; Kinetics; Neurites; Neuroblastoma; Tetradecanoylphorbol Acetate; Vasoactive Intestinal Peptide | 1992 |
Chloride secretagogues stimulate inositol phosphate formation in shark rectal gland tubules cultured in suspension.
Topics: Aluminum; Aluminum Compounds; Animals; Atrial Natriuretic Factor; Biological Transport; Cells, Cultured; Chlorides; Dogfish; Epithelial Cells; Epithelium; Fluorides; Inositol; Inositol Phosphates; Ionomycin; Phospholipids; Salt Gland; Second Messenger Systems; Tritium; Vasoactive Intestinal Peptide | 1991 |
VIP-induced alterations in cAMP and inositol phosphates in the lower esophageal sphincter.
Topics: Animals; Cats; Chromatography, High Pressure Liquid; Cyclic AMP; Cyclic GMP; Cytosol; Esophagus; Female; In Vitro Techniques; Inositol; Inositol Phosphates; Kinetics; Male; Muscle Relaxation; Muscle, Smooth; Vasoactive Intestinal Peptide | 1990 |
Functional interaction between gonadotropin-releasing hormone and PACAP in gonadotropes and alpha T3-1 cells.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Animals; Cell Line; Cyclic AMP; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Inositol; Kinetics; Luteinizing Hormone; Neuropeptides; Neurotransmitter Agents; Pituitary Adenylate Cyclase-Activating Polypeptide; Pituitary Gland; Pituitary Neoplasms; Receptors, LHRH; Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide; Receptors, Pituitary Hormone; RNA, Messenger; Second Messenger Systems; Transcription, Genetic; Vasoactive Intestinal Peptide | 1996 |